| Literature DB >> 33936264 |
Iuliana Sobaru Mohorea1,2, Bogdan Socea3,4, Dragoş Şerban3,5, Zenaida Ceausu6, Adrian Tulin7,8, Violeta Melinte9,10, Mihai Ceausu1.
Abstract
Thyroid cancer accounts for 1% of all malignancies, and is becoming increasingly common worldwide. The literature reports a prevalence of ~50% of thyroid nodules detected during autopsies in subjects with unknown thyroid pathology. An extended retrospective study of 526 autopsy cases was performed to identify the prevalence of thyroid carcinoma, among various types of thyroid nodules identified incidentally. Tissue samples were taken from thyroid nodules, for investigation of the presence of thyroid carcinoma, along with their macroscopic and microscopic features by means of histopathology and immunohistochemistry (IHC) methods. Histopathological diagnosis of malignancy was found in 51 cases of analyzed thyroid samples. Systematic detailed studies demonstrated that a thyroid gland, apparently normal on macroscopic examination, may be the site of pathological manifestations, sometimes presenting carcinomatous findings. Among thyroid carcinomas, the highest frequency was that of papillary microcarcinomas, which have a long evolution, and are incidentally detected during autopsies. Papillary microcarcinoma is an extremely common incidental finding and the vast majority of these tumors pursue a benign course. Furthermore, it is therefore necessary to create national screening programs for the early detection of thyroid carcinoma. Copyright: © Mohorea et al.Entities:
Keywords: papillary microcarcinoma; thyroid nodule; tumor immunophenotype
Year: 2021 PMID: 33936264 PMCID: PMC8082578 DOI: 10.3892/etm.2021.10039
Source DB: PubMed Journal: Exp Ther Med ISSN: 1792-0981 Impact factor: 2.447
Figure 1Localization of tumor nodules in the thyroid gland.
Figure 2Infiltrative thyroid carcinoma of papillary type, with cystic nodular areas, cut section.
Figure 3(A) Thyroid carcinoma: micro-papillary type with psammoma bodies (HE, x40). (B) Papillary carcinoma type with follicular areas (HE, x100). (C) Papillary carcinoma, detail with optical clear, vesicular nuclei (‘Orphan Annie eyes’) (HE, x200). (D) Squamous cell carcinoma (HE, x100). HE, hematoxylin-eosin.
Figure 4Thyroid carcinoma: (A) EMA diffusely positive (IHC, x100), (B) CK7 diffusely positive (IHC, x100), (C) PCNA positive in ~10-15% of tumor cells nuclei (IHC, x200). IHC, immunohistochemistry.